Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the efficacy and safety of different doses and
dose administrations of FP187 compared to a placebo treatment in patients with moderate to
severe plaque psoriasis.